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1. Introduction 
Cystic fibrosis (CF) is inherited as an autosomal recessive disorder in white populations, 
caused by a mutation in a gene that encodes cystic fibrosis transmembrane conductance 
regulator (CFTR) protein, which is expressed in many epithelial cells and blood cells. 
Although CFTR functions mainly as a chloride channel, it has many other regulatory roles, 
including inhibition of sodium transport through the epithelial sodium channel, regulation 
of the outwardly rectifying chloride channel, regulation of ATP channels, regulation of 
intracellular vesicle transport, acidification of intracellular organelles, and inhibition of 
endogenous calcium-activated chloride channels (O’Sullivan & Freedman, 2009; Reisin et al., 
1994; Schwiebert et al., 1995; Stutts et al., 1995; Vankeerberghen et al., 2002; Mehta, 2005). 
CFTR is also involved in bicarbonate–chloride exchange. A deficiency in bicarbonate 
secretion leads to poor solubility and aggregation of luminal mucins (Quinton, 2008). More 
than 1500 CFTR mutations have been identified, but only the functional importance of a 
small number is known. The absence of phenylalanine at position 508 accounts for about 
two-thirds of mutated alleles in northern European and North American populations 
(Walters & Mehta, 2007).  
The clinical manifestations of the disease vary greatly between affected individuals, which 
has led  to interest in the relation between genotype and phenotype. It is presumed that 
disease affects all secretory epithelia including the eye (Castagna, 2001; Turner et al., 2002; 
Mrugacz et al., 2006; Mrugacz et al., 2007; Mrugacz et al., 2007). The pathogenesis of ocular 
changes in CF is still unknown. CF belongs to the group of ocular surface diseases termed 
keratoconjunctivitis sicca or dry eye syndrome. The causes of dry eye are multi-factorial and 
can be connected with deficiencies in any one of the components of the ocular surface and 
tear fluid. It is known that inflammation plays a key role in the pathogenesis of dry eye 
(Baudouin, 2001; Brignole et al., 2000; Pflugfelder, 2004; Pisella et al., 2000), especially with 
the participation of chemokines.  
Chemokines are a family of small protein molecules that play an important role in normal 
leukocyte trafficking as well as in leukocyte recruitment during inflammation. These 
chemokines are grouped into CXC, CC, C, and CX3C subfamilies on the basis of the 
arrangement of the conserved cysteine residues. This molecular subvivision generally 
correlates with their function. Most recently, chemokines have been classified according to 
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their physiological features: inflammatory or inducible chemokines and homeostatic or 
constitutive chemokines. Chemokines act through both specific and shared receptors that 
belong tho the superfamily of G-protein-coupled receptors. The chemokine receptors also 
comprise four groups, including the CC receptors (CCR), which bind CC chemokines; and 
CXC receptors (CXCR), which bind CXC chemokines. Chemokine and chemokine receptor 
expression can increase in acute and chronic inflammatory conditions due to inflammatory 
mediators, such as cytokines. The CC chemokines are involved in the pathogenesis of 
immune-mediated inflammation through monocytes/macrophages activation and 
recruitment. CC chemokines, such as CCL3/macrophage inflammatory protein-1α 
(CCL3/MIP-1α) and CCL4/macrophage inflammatory protein-1ß (CCL4/MIP-1ß) are 
efficient chemoattractant for Th1 cells and contribute to the inflammatory processes in the 
eye (Locati & Murphy, 1999;  Manczak & Yiang, 2002). 
The aim of this study was to assess the potential role of chemokines in the pathogenesis of 
ocular changes in patients with CF. We assayed CCL3/MIP-1α and CCL4/MIP-1ß levels in 
tear fluid of CF patients. We also investigated the correlation between the tear levels of these 
chemokines and clinical severity of CF and ocular surface disease. 
2. Materials and methods 
2.1 Patients 
We studied 28 patients with CF  with a mean age 14.75±3.95 years (range 6-23) (14 women, 
14 men) who attended 3th Department of Pediatric Diseases, Medical University of 
Bialystok, Poland. Twenty-seven normal subjects with a mean age of 15.21±4.35 years (range 
8-23) (13 women, 14 men) were also included. All the CF patients had a comprehensive 
assessment every 6-12 months and were receiving vitamin A supplementation. They did not 
receive any systemic steroid therapy. 
The clinical status was scored according to Schwachmann and Kulczycki (Schwachman 
Score, scale 100-0: 100=excellent, 100-55=without pulmonary insufficiency, below 55=severe 
of CF) (Schwachmann & Kulczycki, 1958). 
2.2 Tear sample collection  
Tear samples were collected in graduated 30-μl disposable microcapillaries (ACCU-FILL 90 
MICROPET, Becton Dickinson and Company, Franklin Lakes, NJ) unilaterally or bilaterally 
from the conjunctival cul-de-sac without anesthesia. Care was taken to avoid touching the 
lid margin or corneal surface. We collected 50 to 100 μl of basal tears from each eye. The 
CCL3/MIP-1α and CCL4/MIP-1ß levels in tears were determined by ELISA using highly 
sensitive immunoassay kit (Endogen system, MA, USA). The collected tears were 
immediately frozen to -80˚C; they were thawed just before assaying. All the samples were 
coded and read blind in the assay. The procedure recommended by the manufacturer was 
followed without any modification.  
2.3 Ophthalmic examination including dry eye tests 
The ophthalmologic examination included subjective assessment, visual acuity and 
biomicroscopy. Subject complaints, such as redness, foreign body sensation, irritation, 
intense burning, and blurred vision were noted. Both patients and controls were performed 
tests for keratoconjunctivitis sicca. Tear break-up time (TBUT) was measured to assess tear 
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Fig. 1. Dry eye tests. 1- Schirmer test, 2- Tear break-up time (TBUT), 3- Lissamine green 
staining 
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film stability. A value of 10 seconds was abnormal. Schirmer test was used to estimate tear 
film quantity; a value of 5 mm after 5 minutes was abnormal. The lissamine green instilled 
into the inferior fornix was used to assess the amount of dead epithelial cells at the ocular 
surface. If two of these variables were abnormal then dry eye syndrome was the diagnosis 
according to the Copenhagen criteria (Manthorpe 1986). All clinical examinations were 
performed before any topical or systemic treatment was administered to the eye. 
2.4 Statistical analysis 
Non- parametric analysis was conducted in this study. Wilcoxon’s sum rank test was used 
to identify differences between tear chemokine levels in patients group and controls. 
Spearman’s rank correlation test was used to establish the significance of correlation 
between tear chemokine levels and severity of CF and the eye disease. A level of p 0.05 was 
accepted as statistically significant. 
3. Results 
3.1 Chemokines levels 
The tear fluid levels of CCL3/MIP-1α were 144.50±18.51 pg/mL (mean±SD) in CF patients, 
whereas in normal controls, they were 41.85±11.25 pg/mL (mean±SD). There is significant 
difference between serum levels of MIP-1α in CF patients and healthy controls  (p=0.001) 
The tear fluid levels of CCL4/MIP-1ß were 4.25±1.15 pg/mL (mean±SD) in CF patients and 
0.52±0.36 pg/mL (mean±SD) in healthy controls. The tear fluid levels of MIP-1beta were 
significantly raised in CF group compared to controls (p<0.001). 
3.2 Assessment of dry eye syndrome 
Dry eye syndrome were observed in 10 (36%) CF patients (five girls and five boys). 
However, the tear fluid levels of CCL3/MIP-1α and CCL4/MIP-1ß were significantly higher 
in CF patients with dry eye syndrome than in CF patients without dry eye symptoms:  
165.50±20.32 pg/mL (mean±SD) and 132.22±17.35 pg/mL  (mean±SD) of CCL3/MIP-1α, 
respectively; and 5.25±1.26 pg/mL (mean±SD) and 3.18±0.80 pg/mL (mean±SD) of 
CCL4/MIP-1ß, respectively (p<0.05). 
3.3 Assessment of pulmonary insufficiency 
Symptoms of pulmonary insufficiency (below 55 according to the Schwachman- Kulczycki 
Score) were found in 45% (13 out of 28) of the CF patients. Spearman correlation coefficient 
indicated a positive correlation between the tear levels of CCL3/MIP-1α and CCL4/MIP-1ß 
and severe clinical status of CF patients (R=0.869, p 0.001). However, negative correlation 
was found between the tear levels of these chemokines and mild CF (R=0.817, p 0.001). 
Fifteen of our CF patients (55%) with high levels of CCL3/MIP-1α and CCL4/MIP-1ß had 
clinical evidence of dry eye. Spearman correlation coefficient indicated a positive correlation 
between the tear levels of these chemokines and dry eye findings in CF patients.  
4. Discussion 
One of the major problems in understanding the mechanisms of dry eye symptoms in CF 
patients, is to determine the factors involved in this disease. It is known that inflammation 
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plays a key role in the pathogenesis of dry eye syndrome, especially with the participation 
of chemokines. Chemokines are expressed at sites of inflammation to attract and amplify 
the leukocyte response. It is important to identify chemokines that play a role in 
mediating response. The recruitment of leukocytes to tissue is essential for inflammation. 
This process may be controlled by MIP-1α and CCL4/MIP-1beta that contribute to the 
recruitment of inflammatory cells into the eye and plays an important role in 
pathogenicity. 
In this study, we have documented, for the first time, raised levels of  CCL3/MIP-1α  and 
CCL4/MIP-1beta in tear fluid in CF patients. The highest levels of these chemokines were 
detected in patients with dry eye syndrome and severe CF. The high levels of suggest of 
CCL3/MIP-1α  and CCL4/MIP-1beta suggest that these chemokines may be produced 
locally and may be a factor for evaluation of the clinical status of this disease.  It may 
confirm the involvement of CCL4/MIP-1beta in the local inflammatory process. Functional 
consequence of elevated levels of these chemokines has yet to be determined exactly. 
Moreover, there is evidence that dry eye stimulates the production of inflammatory 
cytokines from the ocular surface epithelium (Luo et al., 2004). The increased levels of MIP-
1α  and MIP-1beta observed in this study may be a consequence of increased secretion from 
the corneal epithelium or from the another noncorneal cell type. The tear film containing 
numerous specific and nonspecific immune components (Solomon et al., 2001) may act as a 
vehicle of chemokines produced by the lacrimal gland or other epithelia of the ocular 
surface.  
There is a little information about the role of  CCL3/MIP-1α   and CCL4/ MIP-1beta in 
eye inflammation. Despite advances in tissue typing, surgery and immunosuppressive 
treatment allogenic rejection is the most common cause of corneal graft failure. Allograft 
rejection is characterized by infiltration of leucocytes into the donor tissue, a response that 
has been associated with chemokine expression, with CCL2/MCP-1, CCL3/ MIP-1α    and 
CCL4/ MIP-1beta showing ans increased expression in rejected grafts in mice (Yamagami 
et al., 1999). In recent studies of  CCL3/MIP-1α and CCL4/ MIP-1ß,  Verma and others 
have shown that these chemokines were significantly increased in the aqueous humor 
during the active stages of human autoimmune anterior uveitis (AAU) and correlated 
with the clinical severity of the disesase (Verma et al., 1997). Anti-MIP-1α  and anti-MIP-
1ß  treatment suppressed clinical signs of recurrent anterior uveitis (RAU) in the Lewis 
rats, suggesting that these chemokines may also influence the migration of memory T cells 
across the blood ocular barrier in recurring episode of AAU. In addition, during acute 
AAU associated with experimental autoimmune encephalomyelitis (EAE), CC 
chemokines, such as CCL2/MCP-1, CCL5/RANTES, CCL3/MIP-1α and CCL4/MIP-1ß, 
contributed to the inflammatory processes in the eye and central nervous system (CNS) 
(Manczak et al., 2002). Treatment with anti-CCL4/ MIP-1ß delayed onset and reduced 
duration of AAU (Adamus et al., 2001). The retinal ischemia- reperfusion model showed 
an upregulation of CCL4/MIP-1beta in the retinal vessels and these  results confirm that 
this chemokine may be involved in the inflammatory element of pathogenesis of retinal 
neovascularization (Jo et al., 2003). 
5. Conclusion 
In conclusion, the results of this study demonstrate that increased levels of chemokines in 
the tear fluid may play an important role in the pathogenesis of dry eye in patients with 
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cystic fibrosis. The tear levels of CCL3/MIP-1α and CCL4/MIP-1ß may be a candidate 
marker to evaluate the clinical status of cystic fibrosis and eye disease. Our findings may 
contribute to further understanding of local and systemic immune responses and might lead 
to the development of new clinical approaches to inflammatory disorders. Clarification of 
the role of chemokines in the pathogenesis of ocular findings in CF patients will be useful in 
establishing immunotherapeutic strategies for this disease. 
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